Comparison Overview

Cedra Pharmacy

VS

Glenmark Pharmaceuticals

Cedra Pharmacy

1207 Second Avenue, New York, NY, 10065, US
Last Update: 2025-05-04 (UTC)
Between 800 and 900

Strong

Cedra Pharmacy — a growing, dynamic patient and provider-centric specialty pharmacy dedicated to establishing a new, improved standard of patient care and service. Cedra Pharmacy’s comprehensive medication therapy management services provide a unique and specialized approach to focused patient care. From chronic illness to more complex medical conditions, hard to manage therapies are simplified through clinical collaboration. Our goal is to achieve optimal health service outcomes, with maximum financial benefit for your patients. Compassionate, individualized care is our highest priority. Patients receive extensive one-on-one counseling about their medications and administration, while prescription delivery is expedited under proper storage and handling. Cedra Pharmacy works closely with patients to help them understand their financial assistance options and insurance benefits, securing the lowest possible costs. For healthcare providers, Cedra Pharmacy alleviates the often frustrating and time-consuming prior authorization process. Our Assigned Account Team structure personalizes and customizes the service to fit your needs—with an assigned Account Manager, Inside Account Manager, and Pharmacist always available to address any concerns or issues that you may have. Provider and Patient Services: •Customizable/Personalized Service •24 to 72-Hour Time Frame for Referrals •Patient Adherence Program/Medication Refill Reminders •Clinical Support/Expert Consultation •Comprehensive Benefit Investigation •Assistance Obtaining Prior Authorizations •Patient Assistance Program Enrollment •Free Overnight Medication Delivery •Coordination of Nursing Services •Comprehensive Patient Education and Monitoring •Save Time/Prevent Frustration: Whereas other specialty pharmacies ONLY handle prior authorizations that they can directly process or profit from, we facilitate ALL prior authorizations for your office—even if we have to transfer the prescription

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 37
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Glenmark Pharmaceuticals

Glenmark House, B.D.Sawant Marg,, Mumbai, Maharashtra, 400099, IN
Last Update: 2025-05-06 (UTC)

Strong

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 13,607
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/cedra-pharmacy.jpeg
Cedra Pharmacy
ISO 27001
Not verified
SOC 2
Not verified
GDPR
No public badge
PCI DSS
No public badge
https://images.rankiteo.com/companyimages/glenmark-pharmaceuticals.jpeg
Glenmark Pharmaceuticals
ISO 27001
Not verified
SOC 2
Not verified
GDPR
No public badge
PCI DSS
No public badge
Compliance Summary
Cedra Pharmacy
100%
Compliance Rate
0/4 Standards Verified
Glenmark Pharmaceuticals
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Cedra Pharmacy in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Glenmark Pharmaceuticals in 2025.

Incident History — Cedra Pharmacy (X = Date, Y = Severity)

Cedra Pharmacy cyber incidents detection timeline including parent company and subsidiaries

Incident History — Glenmark Pharmaceuticals (X = Date, Y = Severity)

Glenmark Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/cedra-pharmacy.jpeg
Cedra Pharmacy
Incidents

No Incident

https://images.rankiteo.com/companyimages/glenmark-pharmaceuticals.jpeg
Glenmark Pharmaceuticals
Incidents

No Incident

FAQ

Both Cedra Pharmacy company and Glenmark Pharmaceuticals company demonstrate a comparable AI risk posture, with strong governance and monitoring frameworks in place.

Historically, Glenmark Pharmaceuticals company has disclosed a higher number of cyber incidents compared to Cedra Pharmacy company.

In the current year, Glenmark Pharmaceuticals company and Cedra Pharmacy company have not reported any cyber incidents.

Neither Glenmark Pharmaceuticals company nor Cedra Pharmacy company has reported experiencing a ransomware attack publicly.

Neither Glenmark Pharmaceuticals company nor Cedra Pharmacy company has reported experiencing a data breach publicly.

Neither Glenmark Pharmaceuticals company nor Cedra Pharmacy company has reported experiencing targeted cyberattacks publicly.

Neither Cedra Pharmacy company nor Glenmark Pharmaceuticals company has reported experiencing or disclosing vulnerabilities publicly.

Neither Cedra Pharmacy company nor Glenmark Pharmaceuticals company has publicly disclosed detailed information about the number of their subsidiaries.

Glenmark Pharmaceuticals company employs more people globally than Cedra Pharmacy company, reflecting its scale as a Pharmaceutical Manufacturing.

Latest Global CVEs (Not Company-Specific)

Description

Better Auth is an authentication and authorization library for TypeScript. In versions prior to 1.3.26, unauthenticated attackers can create or modify API keys for any user by passing that user's id in the request body to the `api/auth/api-key/create` route. `session?.user ?? (authRequired ? null : { id: ctx.body.userId })`. When no session exists but `userId` is present in the request body, `authRequired` becomes false and the user object is set to the attacker-controlled ID. Server-only field validation only executes when `authRequired` is true (lines 280-295), allowing attackers to set privileged fields. No additional authentication occurs before the database operation, so the malicious payload is accepted. The same pattern exists in the update endpoint. This is a critical authentication bypass enabling full an unauthenticated attacker can generate an API key for any user and immediately gain complete authenticated access. This allows the attacker to perform any action as the victim user using the api key, potentially compromise the user data and the application depending on the victim's privileges. Version 1.3.26 contains a patch for the issue.

Risk Information
cvss4
Base: 9.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Allstar is a GitHub App to set and enforce security policies. In versions prior to 4.5, a vulnerability in Allstar’s Reviewbot component caused inbound webhook requests to be validated against a hard-coded, shared secret. The value used for the secret token was compiled into the Allstar binary and could not be configured at runtime. In practice, this meant that every deployment using Reviewbot would validate requests with the same secret unless the operator modified source code and rebuilt the component - an expectation that is not documented and is easy to miss. All Allstar releases prior to v4.5 that include the Reviewbot code path are affected. Deployments on v4.5 and later are not affected. Those who have not enabled or exposed the Reviewbot endpoint are not exposed to this issue.

Risk Information
cvss4
Base: 4.6
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:H/VA:N/SC:N/SI:N/SA:N/E:U/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Multiple cross-site scripting (XSS) vulnerabilities with Calendar events in Liferay Portal 7.4.3.35 through 7.4.3.111, and Liferay DXP 2023.Q4.0 through 2023.Q4.5, 2023.Q3.1 through 2023.Q3.7, 7.4 update 35 through update 92, and 7.3 update 25 through update 36 allow remote attackers to inject arbitrary web script or HTML via a crafted payload injected into a user’s (1) First Name, (2) Middle Name or (3) Last Name text field.

Risk Information
cvss4
Base: 4.8
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:A/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Python Social Auth is a social authentication/registration mechanism. In versions prior to 5.6.0, upon authentication, the user could be associated by e-mail even if the `associate_by_email` pipeline was not included. This could lead to account compromise when a third-party authentication service does not validate provided e-mail addresses or doesn't require unique e-mail addresses. Version 5.6.0 contains a patch. As a workaround, review the authentication service policy on e-mail addresses; many will not allow exploiting this vulnerability.

Risk Information
cvss4
Base: 6.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Confidential Containers's Trustee project contains tools and components for attesting confidential guests and providing secrets to them. In versions prior to 0.15.0, the attestation-policy endpoint didn't check if the kbs-client submitting the request was actually authenticated (had the right key). This allowed any kbs-client to actually change the attestation policy. Version 0.15.0 fixes the issue.

Risk Information
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X